Skip to main content

trade with estonia

Better Medicine wins EU’s first Apply AI Startup Award

Better Medicine and the winners of the Apply AI Startup Award with Executive Vice-President Henna Virkkunen at the Apply AI Summit

Estonian medical imaging company Better Medicine has won the first Apply AI Startup Award, a European Commission prize for companies applying artificial intelligence in the strategic sectors covered by its Apply AI Strategy.

The award was presented by Executive Vice-President Henna Virkkunen at the Apply AI Summit in Brussels on 17 November, Europreneurs Media reported. Better Medicine was one of three winners, alongside Austria’s Prewave, which monitors supply-chain risk, and Portugal’s blueOASIS, which builds ocean-monitoring systems, and the only healthcare company among them.

The three were chosen from ten finalists headquartered in six member states. National startup associations could nominate up to three companies per country, and a jury picked the winners after the finalists pitched online in October.

Under the award rules, the prize carries no cash: Better Medicine receives a trophy and certificate, a pitching slot on the summit’s main stage, promotion through the Commission’s channels and travel costs for up to two representatives.

A second reader for every scan

Better Medicine’s key product, BMVision Kidney, marks and measures lesions on abdominal CT scans and drafts the measurements into a report. It was the first AI software for kidney cancer detection to receive CE marking under the EU Medical Device Regulation, in early 2025, and Tartu University Hospital, where it was validated, is integrating it into its clinical workflow.

A study published in Nature Communications Medicine had six radiologists at the hospital read 200 CT scans both with and without the software, producing 2,400 readings. Working with the model cut the time needed to identify, measure and report malignant lesions by about a third.

Finding tumours nobody was looking for

Kidney cancer has no population screening programme, and the company says about 60% of cases are found incidentally, on scans ordered for something else. Its argument in Brussels was that the images for broader screening are already being taken: every hospital with a CT scanner holds a stream of abdominal scans in which a small tumour in a kidney is easy to overlook under reporting pressure.

“Every hospital that takes CT scans could be a cancer screening centre,” the company said after the ceremony. “The scans are already there. The technology exists. What is missing is putting it to work at scale,” said Maria Vous, Better Medicine’s chief product officer, describing AI models checking every eligible scan as a second pair of eyes.

From Tartu to the Apply AI Startup Award

Better Medicine was founded in 2020 and develops its models with the University of Tartu’s Institute of Computer Science, part of Estonia’s HealthTech sector. It raised a €1M pre-seed round led by Soulmates Ventures in August 2025 to expand the kidney model in Europe and the United States. The award is recognition rather than financing, but it puts the company in front of the policymakers and industry leaders the summit brought to Brussels.

Are you interested in trading with Estonia? Enterprise Estonia is providing sourcing services for foreign enterprises. Contact Estonian export advisors or use our free e-consulting service to start trade with Estonia.

Request sourcing help
Co-Funded by the European Union